CAS: 612847-09-3 - 1-{1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one

Formel: C₃₄H₂₉N₇O

InChl: InChI=1/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)

Synonyme:

• 1-{1-[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
• 2H-benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]-4-piperidinyl]-
• 3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one
• Akti-1/2

AKT inhibitor VIII

CAS: 612847-09-3

AKT inhibitor VIII (AKTi-1/2) is a highly specific Akt1/2 inhibitor (IC50: 58/210 nM). The selectivity …

• Formel: C₃₄H₂₉N₇O
• Reinheit: 98.65% - 98.77%
• Farbe und Form: Pale Yellow Solid
• Molekulargewicht: 551.64

Akti-1/2

CAS: 612847-09-3

• Formel: C₃₄H₂₉N₇O
• Molekulargewicht: 551.65

Akti-1/2

CAS: 612847-09-3

Akti-1/2 is a potential anticancer agent that inhibits growth and induces apoptosis in cancer cells. …

• Formel: C₃₄H₂₉N₇O
• Reinheit: Min. 95%
• Molekulargewicht: 551.64 g/mol

AKTI-1/2

CAS: 612847-09-3

• Formel: C₃₄H₂₉N₇O
• Reinheit: 97%
• Farbe und Form: Solid
• Molekulargewicht: 551.6404

Akti-1/2

CAS: 612847-09-3

Applications Allosteric Akt (PKB) inhibitors used in synergistic combination therapy for the treatment of cancer.

• Formel: C₃₄H₂₉N₇O
• Farbe und Form: Pale Yellow Solid
• Molekulargewicht: 551.64